Corporate | 9 February 2017 18:41
Baader Bank was successful as joint bookrunner in the sale of the investments held by MIG Fonds in biotech firm Brain AG
|
DGAP-News: Baader Bank AG / Key word(s): Incoming Orders/Miscellaneous
Baader Bank was successful as joint bookrunner in the sale of the investments held by MIG Fonds in biotech firm Brain AG Accompanied by Baader Bank as joint bookrunner, MIG Fonds successfully placed its entire stake held in Brain Biotechnology Research and Information Network AG. The 2,528,389 shares were placed with institutional investors within just a few hours as part of an accelerated book-building process. Because the transaction was oversubscribed several times, the free float of Brain AG shares increased from 22% to 37%. The transaction met with a high level of demand from institutional investors in Germany, the UK, Switzerland and France. MIG Fonds is a VC investor in the biotech and medtech sector and had held investments in the company through several of its funds since 2006. It successfully accompanied Brain AG’s IPO in February 2016.
09.02.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
|
| Language: | English |
| Company: | Baader Bank AG |
| Weihenstephaner Str. 4 | |
| 85716 Unterschleissheim | |
| Germany | |
| Phone: | +49 89 5150 1013 |
| Fax: | +49 89 5150 29 1880 |
| E-mail: | communications@baaderbank.de |
| Internet: | www.baaderbank.de |
| ISIN: | DE0005088108 |
| WKN: | 508810 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich (m:access), Stuttgart, Tradegate Exchange; Open Market in Frankfurt |
| End of News | DGAP News Service |